(SOURCE: JOHNS HOPKINS MEDICINE) – An international research group of 32 experts from nine countries has updated the guidelines for diagnosing the genetic disease cystic fibrosis. The researchers expect that these guidelines will provide better direction for clinicians looking at patients with symptoms of the disease to make a correct diagnosis and recommend personalized treatment. […]
(SOURCE: UNIVERSITY OF NOTTINGHAM) – Future research has the potential power to transform treatments for cystic fibrosis. Yet patients with the condition – and the people who care for them – have traditionally had little say in where studies should focus their efforts. Now a partnership led by academics at The University of Nottingham has offered […]
(SOURCE: OSAKA UNIVERSITY) – Fibrosis is a form of scarring that could if uncontrolled cause deleterious thickening of tissues. Although it is known that fibrosis is caused by an activated immune system, which specific cells are responsible continuous to elude researchers. Scientists at IFReC may have found this subgroup, as they report in Nature a class […]
(SOURCE: UNIVERSITY OF PITTSBURGH SCHOOLS OF THE HEALTH SCIENCES) – The chronic lung inflammation that is a hallmark of cystic fibrosis, has, for the first time, been linked to a new class of bacterial enzymes that hijack the patient’s immune response and prevent the body from calling off runaway inflammation, according to a laboratory investigation led by […]
(SOURCE: THE ROCKAFELLER UNIVERSITY) Rockefeller scientists have created the first three-dimensional map of the protein responsible for cystic fibrosis, an inherited disease for which there is no cure. This achievement, described December 1 in Cell, offers the kinds of insights essential to better understanding and treating this often-fatal disease, which clogs the lungs with sticky […]
(UNIVERSITY OF CAMBRIDGE) According to a recent press release, a multi-drug resistant infection that can cause life-threatening illness in people with cystic fibrosis (CF) and can spread from patient to patient has spread globally and is becoming increasingly virulent, according to new research published today in the journal Science.
(Healio) According to an article recently published in Healio, Vertex Pharmaceuticals announced the FDA approval of Orkambi for treatment of cystic fibrosis in children aged 6 to 11 years who have two copies of the F508del mutation, according to a news release.
(Cystic Fibrosis News Today) According to an article posted in Cystic Fibrosis News Today, a recent study has shown that sputum and throat swabs of adult cystic fibrosis patients can help identify Pseudomonas aeruginosa and Staphylococcus aureuslung infections.
Cystic fibrosis: (PR Newswire) According to a recent press release, “The preclinical study comparing PUR1900 to the oral reference product shows that PUR1900 offers a significant advantage over the current standard of care for treating fungal infections in the lungs,” said David Hava, Ph.D., Chief Scientific Officer for Pulmatrix.